Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
04.02.26
/
50%
€282.50
Target price
04.02.27
€350.97
Performance (%)
6.03%
Price
18.06.26
€294.50
Summary
This prediction is currently active. With a performance of 6.03%, the BUY prediction by The_Goldman_Sachs_Gr for Amgen Inc. is trending in the right direction. A total of €5.04 was paid as dividends for this prediction. This prediction currently runs until 04.02.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -3.648% | -3.648% |
| iShares Core DAX® | 1,75 % | 2,66 % |
| iShares Nasdaq 100 | 4,30 % | 6,59 % |
| iShares Nikkei 225® | 9,89 % | 18,28 % |
| iShares S&P 500 | 2,54 % | 3,06 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $403.00 to $415.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat